Edge Wealth Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Edge Wealth Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$4K	–	590
2017 Q4	$4K	Hold	100	–	–	﹤0.01%	461
2017 Q3	$4K	Hold	100	–	–	﹤0.01%	463
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	473
2017 Q1	$2K	Hold	100	–	–	﹤0.01%	466
2016 Q4	$2K	Hold	100	–	–	﹤0.01%	440
2016 Q3	$3K	Buy	+100	New	+$3.11K	﹤0.01%	426
2015 Q3	–	Sell	-250	Closed	-$13K	–	487
2015 Q2	$13K	Buy	+250	New	+$13.3K	﹤0.01%	286

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Edge Wealth Management's JUNO Position: Q1 2018 in Review

Edge Wealth Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 100 shares — an estimated $4K sold.

Edge Wealth Management first reported a position in JUNO in Q2 2015 and held it in 7 quarters. The position peaked at $13K in Q2 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Edge Wealth Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Edge Wealth Management sold 100 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $4K.
Edge Wealth Management first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
Edge Wealth Management's Juno Therapeutics, Inc. position peaked at $13K in Q2 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Edge Wealth Management's 13F filing for Q1 2018, filed 5 Apr 2018.